ER,FOXA1 and GATA3 are three of the definingsignature genes consistently observed in ER+ breast cancers (48, 49), and all three proteins have been shown to be required for theestablishment of an oestrogen-responsive ER complex (50). This evidence concerns the gene FOXA1 and breast cancer.